Celltrion acquires US biopharma plant from Eli Lilly to counter tariff threats
Seoul, Sep 23 (IANS) Celltrion, South Korea's leading biopharmaceutical company, said on Tuesday its US subsidiary has signed a deal to acquire a US biopharmaceutical production facility, a move it said will "eliminate" risks from looming…
Read More...
Read More...